Azelastin/Fluticason AL Nasenspray

Medicinal product

(Invented) name

Azelastin/Fluticason AL Nasenspray

Active substance (s)

Azelastino hidrochloridas/Flutikazono propionatas

Strength

137 µg/50 µg/dozėje

Pharmaceutical form

nosies purškalas (suspensija)

Route (s) of administration

vartoti į nosį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R01AD58, Fluticasone, combinations

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-05-27

Date of renewal

Documents

2603_Azelastin 137mcg50mcg_PIL.docx

2603_Azelastin 137mcg50mcg_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Vienoje dozėje (0,14 g) yra:	1 dozėje
Azelastino hidrochloridas	137 µg
Flutikazono propionatas	50 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117745	103849	1103849	buteliukas	120 dozių N1		Receptinis	LT/L/25/2603/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-05-27	Registruotas